Plasma adiponectin and leptin concentrations in professional rugby players

Journal of Biological Regulators and Homeostatic Agents

Volumn 24, Issue 1, 2010, Pages 87-91

  Magni, Paolo ^a   Ruscica, M ^a   Dozio, E ^a   Passafaro, L ^a   Stefani, L ^a   Morelli, P ^b   Banfi, G ^a,b   Corsi, M M ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

Author keywords

Adipokines; Adiponectin; Body composition; Leptin; Rugby players

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; LEPTIN; ADIPONECTIN, HUMAN;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; MALE; NEUROENDOCRINE SYSTEM; NORMAL HUMAN; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RUGBY; ATHLETIC PERFORMANCE; BLOOD; COHORT ANALYSIS; FOOTBALL; IMPEDANCE; OBESITY; PHYSIOLOGY;

ADIPONECTIN; ADIPOSITY; ADULT; ATHLETIC PERFORMANCE; BODY COMPOSITION; BODY MASS INDEX; COHORT STUDIES; ELECTRIC IMPEDANCE; FOOTBALL; HUMANS; LEPTIN; MALE; YOUNG ADULT;

EID: 77953702253     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92:347-55.
2. Van Dielen FMH, Van 't Veer C, Buurman WA, Greve JWM. Leptin and soluble leptin receptor levels in obese and weight-losing individuals. J Clin Endocrinol Metab 2002; 87:1708-16.
3. Magni P, Liuzzi A, Ruscica M, et al. Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference. Clin Endocrinol (Oxf) 2005; 62:189-96.
4. Haluzik M, Boudova L, Nedvidkova J, et al. Lower serum leptin concentrations in rugby players in comparison with healthy non-sporting subjects - relationships to anthropometric and biochemical parameters. Eur J Appl Physiol Occup Physiol 1998; 79:58-61. (Pubitemid 29041373)
5. Unal M, Unal DO, Baltaci AK, Mogulkoc R, Kayserilioglu A. Investigation of serum leptin levels in professional male football players and healthy sedentary males. Neuro Endocrinol Lett 2005; 26(2):148-51.
6. Haluzik M, Haluziková D, Boudová L, et al. The relationship of serum leptin levels and parameters of endurance training status in top sportsmen. Endocr Res 1999; 25:357-69.
7. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002; 13:84-9.
8. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86:1930-5.
9. Jurimae J, Purge P, Jurimae T. Adiponectin and stress hormone responses to maximal sculling after volume-extended training season in elite rowers. Metabolism 2006; 55:13-9.
10. Perseghin G, Burska A, Lattuada G, et al. Increased serum resistin in elite endurance athletes with high insulin sensitivity. Diabetologia 2006; 49:1893-900.
11. Jurimae J, Purge P, Jurimae T. Adiponectin is altered after maximal exercise in highly trained male rowers. Eur J Appl Physiol 2005; 93:502-5.
12. Mayr FB, Spiel AO, Leitner JM, et al. Influence of the Duffy antigen on pharmacokinetics and pharmacodynamics of recombinant monocyte chemoattractant protein (MCP-1, CCL-2) in vivo. Int J Immunopathol Pharmacol 2009; 22:615-25.
13. Szkodzinski J, Blazelonis A, Wilczek K, et al. The role of interleukin-6 and transforming growth factor-beta1 in predicting restenosis within stented infarct-related artery. Int J Immunopathol Pharmacol 2009; 22:493-500.
14. Frezza D, Giambra V, Mattioli C, et al. Allelic frequencies of 3′ Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia. Int J Immunopathol Pharmacol 2009; 22:115-23.
15. Negrev NN, Radev RZ, Velikova MS, Anogeianaki A. Effects of the hormones of the thyroid axis on the vitamin K-dependent plasma factors of blood coagulation (II, VII, IX, and X). Int J Immunopathol Pharmacol 2008; 21:221-6.
16. Rodríguez A, Catalán V, Gómez-Ambrosi J, Frühbeck G. Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? Curr Pharm Des 2007; 13:2169-75.